Business Context and Reporting Period
Company: U.S. Bancorp
Filing Type: Form 8-K (Current Report)
Report Date: January 31, 2007
Event Date: January 31, 2007 (Pricing); February 6, 2007 (Closing)
This filing reports the pricing and subsequent closing of a private placement of floating rate convertible senior debentures.
Key Financial Metrics
- Debt Issuance: $3.0 billion aggregate principal amount of floating rate convertible senior debentures due 2037.
- Overallotment Option: Initial purchaser has an option to purchase up to an additional $450 million.
- Underwriting Costs: $22.5 million in purchase discounts/commissions ($28.875 million if overallotment is fully exercised).
- Interest Rate: Three-month LIBOR minus 1.75% (reset quarterly), with a floor of 0% per annum.
- Conversion Terms: Initial conversion rate of 24.4260 shares per debenture, representing a ~15% premium over the $35.60 closing stock price on January 31, 2007.
Material Changes
The filing discloses a significant capital structure change through the issuance of $3.0 billion in convertible debt. This transaction increases the company's debt load while providing potential future equity dilution contingent on stock price performance exceeding the conversion price.
Outlook, Risks, and Unusual Items
- Interest Payment Structure: Interest is payable quarterly until February 6, 2032. After this date, interest payments cease, and holders receive an accreted principal amount based on a variable yield.
- Conversion Mechanics: Holders may convert at any time prior to February 6, 2037. Conversion results in cash payment up to the principal amount plus shares of common stock only if the market price exceeds the conversion price. The company retains the option to cash settle delivery obligations.
- Regulatory Status: Securities were issued pursuant to Section 4(2) of the Securities Act and resold to qualified institutional buyers under Rule 144A.
Investor Verification Checklist
- Verify the final exercise status of the $450 million overallotment option.
- Confirm the impact of the $3.0 billion issuance on the company's leverage ratios and liquidity position.
- Monitor the company's common stock price relative to the conversion price to assess potential dilution risk.
- Review the specific terms of the variable yield accretion mechanism effective after February 6, 2032.